The 20 Best Hemimegalencephaly Doctors Near Me in District of Columbia, US

Chima Oluigbo, MD, FRCSC, FAANS, is a pediatric neurosurgeon at Children’s National Hospital and Professor of Neurological Surgery, Neurology and Pediatrics at the George Washington University School of Medicine. He completed his residency in neurological surgery at University Hospitals Birmingham, England and subsequently completed fellowships at the University of Colorado (pediatric neurosurgery) and the Ohio State University (functional and stereotactic neurosurgery). He is board certified by the American Board of Pediatric Neurological Surgery and the Royal College of Physicians and Surgeons of Canada. He is a Fellow of the American Association of Neurological Surgeons (AANS) and an active member of the Congress of Neurological Surgeons (CNS) and the AANS/CNS Section on Pediatric Neurological Surgery. Dr. Oluigbo cares for children with all types of diseases of the nervous system such as epilepsy, brain and spine tumors, hydrocephalus, craniosynostosis, spina bifida and tethered spinal cord. He specializes in the surgical care of children with epilepsy as well as pediatric functional and restorative neurosurgery. He uses minimally invasive techniques to treat patients with epilepsy. These techniques include the Visualase laser ablation therapy and the ROSA robot assisted epilepsy surgery. He also uses advanced intraoperative magnetic resonance imaging (iMRI) during epilepsy surgery to optimize seizure control outcomes. Dr. Oluigbo previously led the epilepsy surgery service at the Ohio State University Medical Center where he was actively involved in functional neurosurgery (deep brain stimulation). His research interests include epilepsy surgery, deep brain stimulation, functional neurological restoration and the development of innovative neuromodulation therapies for the treatment of chronic neurological disorders including epilepsy, movement disorders, neurobehavioral and cognitive disorders, chronic pain and spasticity in children. Dr. Oluigbo is rated as a Distinguished provider by MediFind in the treatment of Hemimegalencephaly. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Cortical Dysplasia, Epilepsy, Seizures, Posterior Fossa Decompression, and Craniectomy. Dr. Oluigbo is board certified in American Board Of Pediatric Neurological Surgery, 2014.

William D. Gaillard, MD, professor of neurology and neurophysiology, is chief of the Divisions of Child Neurology and of Epilepsy and Neurophysiology. He is director of the Comprehensive Pediatric Epilepsy Program — one of the leading multidisciplinary pediatric epilepsy programs in the country. As associate director of the Children’s National Research Institute’s Center for Neuroscience Research, he is responsible for overseeing and organizing clinical neuroscience research. Dr. Gaillard is professor of pediatrics and neurology at the George Washington University School of Medicine; Professor of Neurology, Georgetown University; and Adjunct Professor of Hearing and Speech Sciences, University of Maryland, College Park. Additionally, Dr. Gaillard holds longstanding collaborations with the Clinical Epilepsy Section (CES), National Institute of Neurological Disorders and Stroke and NIH. His innovative research utilizes advanced structural and functional imaging to examine the effects of epilepsy on brain structure and function. His pioneering work with functional imaging has changed clinical practice for patients with epilepsy, made important technical contributions to structural and functional imaging methods, and provided fundamental scientific insights on the biology of brain plasticity. Ultimately, the goal of his research is to improve the outcomes and lives of children with epilepsy. Dr. Gaillard is a past president of the American Epilepsy Society. He is past treasurer of the American Epilepsy Society, past chair of the International League Against Epilepsy (ILAE) Commission on Diagnostics, past chair of the ILAE Pediatric Epilepsy Surgery Task Force and past member of the Pediatric Commission. He is a past editor of Epilepsy Research and a past editor of Epilepsia. He is the author of more than 240 peer-reviewed scientific papers and more than 50 chapters and holds longstanding federal and foundation grant funding. Dr. Gaillard is rated as a Distinguished provider by MediFind in the treatment of Hemimegalencephaly. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Status Epilepticus, Liver Embolization, and Deep Brain Stimulation. Dr. Gaillard is board certified in American Board Of Psychiatry And Neurology, Pediatrics: American Board Of Pediatrics, 2005, and American Board Of Psychiatry And Neurology, 1992.

Ersida Buraniqi is a Pediatric Neurologist practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 11 years. Dr. Buraniqi is rated as an Advanced provider by MediFind in the treatment of Hemimegalencephaly. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Seizures, Epilepsy in Children, Epilepsy, Hemimegalencephaly, and Liver Embolization. Dr. Buraniqi is board certified in American Board Of Psychiatry And Neurology, 2024 and Neurology With Special Qualification In Child Neurology: American Board Of Psychiatry And Neurology, 2023.

Fellows are fully credentialed, board-certified providers who can independently practice medicine but are in further training in their specialty. This specialty training is under the supervision of an attending physician. Dr. Gumayan is rated as an Experienced provider by MediFind in the treatment of Hemimegalencephaly. Her clinical expertise encompasses Focal or Multifocal Malformations in Neuronal Migration, Hemimegalencephaly, Increased Head Circumference, Hydrocephalus, and Liver Embolization.

Youssef A. Kousa, MS, DO, PhD, is a physician-scientist specializing in neonatal neurology at Children’s National Hospital in Washington, D.C. During his pediatric internship, he founded an international, trans-disciplinary research team, the Prenatal Infection and Neurodevelopmental Genetics Consortium, to study the 2015 Zika virus pandemic and model human genetic modifiers in neuroinfectious diseases and neurodevelopmental disorders. The goal of this group is disease prevention by integrating and leveraging team science, systems biology and genomics. Dr. Kousa is the principal investigator of the Consortium, which now includes 19 co-investigators representing 13 different institutions. Partnering with the National Institutes of Health and Centers for Disease Control and Prevention, the Consortium is bringing together mother-infant dyad cohorts with 12,000 participants throughout the Western Hemisphere. Dr. Kousa completed a combined pediatrics and child neurology residency at Children’s National and the DO-PhD Physician Scientist Training Program at Michigan State University. Through graduate and post-graduate research training, he has focused on human genetics, genetic engineering, developmental biology, immunology and virology. His accomplishments include creation of an adenovirus-based malaria vaccine, discovery of a conserved gene regulatory network in craniofacial and neural tube development, 30 peer-reviewed publications, and multiple national and international invited research presentations. His awards and honors span academic, research, service and leadership roles, including the highest honors possible at Michigan State University for a graduate and medical student. Dr. Kousa directs the Perinatal Neuroinfections Clinic at Children’s National and is an instructor in Neurology, Pediatrics, and Genomics and Precision Medicine at George Washington University School of Medicine, Washington, D.C. Prenatal Infection and Neurodevelopmental Genetics Consortium Publications Google Scholar|ORCiD. Dr. Kousa is rated as an Experienced provider by MediFind in the treatment of Hemimegalencephaly. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Popliteal Pterygium Syndrome, Van Der Woude Syndrome, Arthrogryposis Multiplex Congenita, Anencephaly, and Liver Embolization. Dr. Kousa is board certified in American Board Of Psychiatry And Neurology, 2020.

Kuntal Sen, MD, is the co-director of Neurogenetics Clinic in the Division of Neurogenetics and Neurodevelopmental Pediatrics at Children's National Hospital. He is a graduate of Grant Government Medical College, Mumbai. He completed a combined pediatrics-medical genetics and genomics residency at the Detroit Medical Center/Wayne State University of Medicine. He then completed a child neurology fellowship at Children’s National. He also worked at the National Institutes of Health as a volunteer for the Undiagnosed Diseases Program. He is one of the few physicians in the country with dual training in neurology and clinical genetics which affords him a unique expertise to diagnose and manage patients with complex monogenic neurological disorders. Dr. Sen’s clinical expertise is centered on providing long-term, holistic, and family-centered care for patients with mitochondrial diseases and other ultra-rare neuro-metabolic disorders. Dr. Sen's research focus is on multi-modal neuroimaging and neuromonitoring in inborn errors of metabolism. Dr. Sen has published several peer-reviewed articles and presented at many international conferences on newborn screening disorders, rare neurometabolic epilepsies and ethics in genetic testing. Dr. Sen spearheaded a national survey aimed at identifying innovative approaches to educate child neurologists about genomic testing. This initiative culminated in the development and release of a national curriculum through the Child Neurology Society, under his leadership. He was elected chair of the Neurogenetics Section of the American Academy of Neurology, reflecting his national recognition in the field. He is a fellow of the American College of Medical Genetics (ACMG) and a member of the ACMG Advocacy and Government Affairs Committee. He also serves as the media editor for the Pediatric Neurology Journal. During his medical training, he has won awards and grants from professional societies including the prestigious ACMG Foundation/Perkin Elmer Award and Children’s National Founders Auxiliary Board Grant. Publications Google Scholar. Dr. Sen is rated as an Experienced provider by MediFind in the treatment of Hemimegalencephaly. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Urea Cycle Disorders (UCD), Hydranencephaly, Lissencephaly 2, and Cortical Dysplasia. Dr. Sen is board certified in American Board Of Psychiatry And Neurology, 2022 and Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2019.

Samir Sur is a Neurosurgery provider practicing medicine in Washington, Washington, D.c.. Dr. Sur is rated as an Experienced provider by MediFind in the treatment of Hemimegalencephaly. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Stroke, Brain Aneurysm, Cerebral Arteriovenous Malformation, Thrombectomy, and Stent Placement. Dr. Sur is currently accepting new patients.